Canaccord Genuity Reinstates Buy on Crew Energy, Announces C$9 Price Target
Canaccord Genuity analyst Mike Mueller reinstates Crew Energy (TSX:CR) with a Buy and announces C$9 price target.
Canaccord Genuity Reinstates Buy on Tamarack Valley Energy, Announces C$6 Price Target
Canaccord Genuity analyst Mike Mueller reinstates Tamarack Valley Energy (TSX:TVE) with a Buy and announces C$6 price target.
HC Wainwright & Co. Initiates Coverage On Acasti Pharma with Buy Rating, Announces Price Target of $2.4
HC Wainwright & Co. analyst Oren Livnat initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Buy rating and announces Price Target of $2.4.
Guggenheim Initiates Coverage On Vaxcyte with Buy Rating, Announces Price Target of $66
Guggenheim analyst Seamus Fernandez initiates coverage on Vaxcyte (NASDAQ:PCVX) with a Buy rating and announces Price Target of $66.
Redburn Partners Initiates Coverage On Estee Lauder Cos with Sell Rating, Announces Price Target of $210
Redburn Partners analyst Christopher Pitcher initiates coverage on Estee Lauder Cos (NYSE:EL) with a Sell rating and announces Price Target of $210.
Citigroup Initiates Coverage On Aon with Neutral Rating, Announces Price Target of $339
Citigroup analyst Michael Ward initiates coverage on Aon (NYSE:AON) with a Neutral rating and announces Price Target of $339.
UBS Initiates Coverage On Camden Prop Trust with Buy Rating, Announces Price Target of $137
UBS analyst Michael Goldsmith initiates coverage on Camden Prop Trust (NYSE:CPT) with a Buy rating and announces Price Target of $137.
UBS Initiates Coverage On Essex Property Trust with Neutral Rating, Announces Price Target of $226
UBS analyst Michael Goldsmith initiates coverage on Essex Property Trust (NYSE:ESS) with a Neutral rating and announces Price Target of $226.
BMO Capital Initiates Coverage On Diversey Hldgs with Market Perform Rating, Announces Price Target of $5.8
BMO Capital analyst John McNulty initiates coverage on Diversey Hldgs (NASDAQ:DSEY) with a Market Perform rating and announces Price Target of $5.8.
UBS Initiates Coverage On UDR with Neutral Rating, Announces Price Target of $43
UBS analyst Michael Goldsmith initiates coverage on UDR (NYSE:UDR) with a Neutral rating and announces Price Target of $43.